Breast Cancer Steering Committee Roster
The Breast Cancer Steering Committee (BCSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult breast cancer. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The BCSC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Shelley Hwang, M.D., M.P.H.
Duke University Medical Center
Durham, NC
Kathy D. Miller, M.D.
Indiana University Simon Cancer Center
Indianapolis, IN
Members
Sunil Badve, M.B.B.S., M.D., FRCPath.
Emory University School of Medicine
Atlanta, GA
Karla Ballman, Ph.D.
Weill Cornell Medical College
New York, NY
Mark Basik, M.D.
McGill University
Montréal, QC, Canada
Lisa Carey, M.D.
University of North Carolina Lineberger Comprehensive Cancer Center
Chapel Hill, NC
Stephen Chia, M.D.
British Columbia Cancer Agency
Vancouver, BC, Canada
Angela DeMichele, M.D., M.S.C.E.
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA
Jared Foster, Ph.D.
National Cancer Institute
Bethesda, MD
Jami Fukui, M.D.
University of Hawai'i Cancer Center
Honolulu, HI
Elizabeth Garrett-Mayer, PhD
American Society of Clinical Oncology
Alexandria, VA
Matthew Goetz, M.D.
Mayo Clinic
Rochester, MN
Lisa R. Hayes, J.D.
Pink-4-Ever Ending Disparities
Indianapolis, IN
Larissa Korde, M.D., M.P.H.
National Cancer Institute
Bethesda, MD
Stanley Lipkowitz, M.D., Ph.D.
National Cancer Institute
Bethesda, MD
Eleftherios P. Mamounas, M.D., M.P.H.
University of Florida Health Cancer Center
Orlando, FL
Ann H. Partridge, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Lajos Pusztai, M.D., D.Phil.
Yale University
New Haven, CT
Eileen Rakovitch, M.D., M.Sc.
Sunnybrook Health Sciences Centre
Toronto, ON, Canada
Kathryn Ruddy, M.D.
Mayo Clinic
Rochester, MN
Priyanka Sharma, M.D.
University of Kansas Medical Center
Westwood, KS
Mary Lou Smith, J.D., M.B.A.
Research Advocacy Network
Plano, TX
Alyssa Throckmorton, M.D., FACS
Baptist Memorial Health System/Mid-South MU NCORP
Memphis, TN
Sara Tolaney, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Julia White, M.D.
Ohio State University
Columbus, OH
Antonio C. Wolff, M.D.
Johns Hopkins University
Baltimore, MD
Richard C. Zellars, M.D.
Indiana University
Indianapolis, IN
Fengmin Zhao, Ph.D., M.H.S.
Harvard University Medical School
Boston, MA
NCI CCCT Program Director
Elena Schwartz, Ph.D.
elena.schwartz@nih.gov